Prolactin, prolactin disorders, and dopamine agonists during pregnancy

被引:7
|
作者
Levin, Gabriel [1 ]
Rottenstreich, Amihai [1 ]
机构
[1] Hadassah Univ Hosp, Dept Obstet & Gynecol, POB 12000, IL-91120 Jerusalem, Israel
关键词
Dopamine agonists; Pregnancy; Prolactinoma; PITUITARY-GLAND; RELEASE; RECEPTOR; HYPERPROLACTINEMIA; POSTPARTUM; MANAGEMENT; DIAGNOSIS; SOCIETY; GROWTH; WOMEN;
D O I
10.1007/s42000-018-0071-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary disorders, and especially prolactinomas, are not common among pregnant women, though they tend to occur during a woman's years of fertility. The majority of prolactinoma patients present with infertility and menstruation dysfunction; however, prolactinomas are associated with potentially significant morbidity if they remain unrecognized and untreated. Herein, we survey the role of prolactin and prolactinomas in pregnancy while also outlining the therapeutic approach to prolactinoma during pregnancy. The current literature on the impact of dopamine agonists during pregnancy is also reviewed.
引用
收藏
页码:137 / 139
页数:3
相关论文
共 50 条
  • [1] Prolactin, prolactin disorders, and dopamine agonists during pregnancy
    Gabriel Levin
    Amihai Rottenstreich
    Hormones, 2019, 18 : 137 - 139
  • [2] SUPPRESSION OF PROLACTIN BY DOPAMINE AGONISTS IN SCHIZOPHRENICS AND CONTROLS
    ROTROSEN, J
    ANGRIST, B
    CLARK, C
    GERSHON, S
    HALPERN, FS
    SACHAR, EJ
    AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (08): : 949 - 951
  • [3] THE SENSITIVITY OF PROLACTIN SECRETION TO DOPAMINE CHANGES DURING PREGNANCY IN MICE
    SWARTZ, SR
    OGREN, L
    TALAMANTES, F
    ACTA ENDOCRINOLOGICA, 1986, 111 (04): : 567 - 571
  • [4] PROLACTIN IMPLANTS IN THE HYPOTHALAMUS INHIBIT PROLACTIN SURGES DURING PREGNANCY AND ALTER PROLACTIN-RELEASE IN RESPONSE TO DOPAMINE RECEPTOR BLOCKADE
    VIDAL, G
    MATHIASEN, JR
    VOOGT, JL
    JOURNAL OF NEUROENDOCRINOLOGY, 1991, 3 (03) : 249 - 252
  • [5] DOPAMINE AND PROLACTIN IN HUMAN-PREGNANCY
    BENJONATHAN, N
    MUNSICK, RA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (05): : 1019 - 1025
  • [6] Metabolic effects of prolactin and the role of dopamine agonists: A review
    Kirsch, Polly
    Kunadia, Jessica
    Shah, Shruti
    Agrawal, Nidhi
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center
    Prencipe, Nunzia
    Bona, Chiara
    Cuboni, Daniela
    Berton, Alessandro Maria
    Bioletto, Fabio
    Varaldo, Emanuele
    Aversa, Luigi Simone
    Sibilla, Michela
    Gasco, Valentina
    Ghigo, Ezio
    Grottoli, Silvia
    PITUITARY, 2024, 27 (03) : 269 - 276
  • [8] ULTRASTRUCTURAL MORPHOMETRY OF PROLACTIN SECRETING ADENOMAS TREATED WITH DOPAMINE AGONISTS
    SCHOTTKE, H
    SAEGER, W
    LUDECKE, DK
    CASELITZ, J
    PATHOLOGY RESEARCH AND PRACTICE, 1986, 181 (03) : 280 - 290
  • [9] EVALUATING PROLACTIN RESPONSE TO DOPAMINE AGONISTS IN SCHIZOPHRENIA - METHODOLOGICAL PROBLEMS
    DAVIS, BM
    DAVIS, KL
    MOHS, RC
    MATHE, AA
    ROTHPEARL, AB
    JOHNS, CA
    LEVY, MI
    HORVATH, TB
    ARCHIVES OF GENERAL PSYCHIATRY, 1985, 42 (03) : 259 - 264
  • [10] LYSOSOMAL ACTIVITY IN PROLACTIN CELLS UNDER THE EFFECT OF DOPAMINE AGONISTS
    BACSY, E
    MOI, VD
    RAPPAY, G
    GAAL, G
    ACTA HISTOCHEMICA, 1986, : 221 - 224